FindTrial
Sign In

A study to evaluate the prevalence of gut bacteria in stool of humans and poultry, and in drinking water sources, and compare their antibiotic response, thereby establishing the significance of the One Health concept

Approaching One Health concept through assessing presence of faecal carbapenem-resistant Enterobacterales in humans, farm poultry and water - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/07/071374
Enrollment
120
Registered
2024-07-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z000- Encounter for general adult medical examination

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adults from community who have not received any known antibiotic for at least six months. 2. Adult patients admitted in Medicine wards / ICU who are currently on carbapenem therapy. 3. Fully grown broilers from commercial farms / markets

Exclusion criteria

Exclusion criteria: Individuals with any known gastro-intestinal illness.

Design outcomes

Primary

MeasureTime frame
1. Proportion of faecal carriage of carbapenem-resistant Enterobacterales (CRE) in community, hospitalized patients and poultry, as well as their presence in supply water will be known. 2. The antimicrobial resistance patterns of the isolated CRE will be compared. Timepoint: At baseline only—

Secondary

MeasureTime frame
Type of carbapenemase enzymes & the genes encoding them in the isolated strains will be knownTimepoint: At baseline only—

Countries

India

Contacts

Public ContactDr Prabhav Aggarwal

Maulana Azad Medical College

prabhavaggarwal@yahoo.co.in9899303626

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026